Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00592436 · ClinicalTrials.gov registry record
Screening Protocol for Children and Adolescents With Attention Deficit Hyperactivity Disorder
A clinical trial, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- 663
- Enrollment target
NCT00592436: Clinical Trial study, sponsored by Massachusetts General Hospital.
NCT00592436 is a clinical trial that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 663 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00592436 was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- 663 participants
- Enrollment target
Study Summary
The objective of this protocol is to establish a comprehensive screening process to evaluate the eligibility of potential pediatric subjects for appropriate ADHD clinical research studies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 663 participants |
| Start Date | 2003-03 |
| Est. Completion | 2015-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00592436
The ClinicalTrials.gov registry entry for NCT00592436 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 663 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00592436 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00592436 about?
NCT00592436 is a clinical study titled "Screening Protocol for Children and Adolescents With Attention Deficit Hyperactivity Disorder". The objective of this protocol is to establish a comprehensive screening process to evaluate the eligibility of potential pediatric subjects for appropriate ADHD clinical research studies.
What is the current status of trial NCT00592436?
This trial is currently terminated. The enrollment target is 663 participants. The study started on 2003-03. Estimated completion is 2015-05.
Who is sponsoring clinical trial NCT00592436?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.